Product image of Ipratropiumbromide/Salbutamol Sandoz (Ipratropium Bromide, Salbutamol) supplied by GNH India

Ipratropiumbromide/Salbutamol Sandoz

Active Ingredient:
Ipratropium Bromide, Salbutamol
Origin:
EU

Ipratropiumbromide/Salbutamol Sandoz (Ipratropium Bromide, Salbutamol)

Ipratropium bromide and Salbutamol, the active ingredients in Ipratropiumbromide/Salbutamol Sandoz, are an anticholinergic bronchodilator and a β2‑adrenergic agonist presented as a combination inhalation solution for inhalation use. It provides bronchodilation for patients with chronic obstructive pulmonary disease, asthma and acute bronchospasm.

GNH India supplies Ipratropiumbromide/Salbutamol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ipratropiumbromide/Salbutamol Sandoz is a combination bronchodilator used in respiratory disorders that cause airway narrowing.

  • Chronic obstructive pulmonary disease (COPD): improves airflow and reduces bronchospasm.
  • Asthma: provides rapid bronchodilation to relieve symptoms.
  • Acute bronchospasm: quickly alleviates sudden airway constriction.

How It Works

  • Ipratropium bromide blocks muscarinic receptors in airway smooth muscle, preventing acetylcholine‑mediated bronchoconstriction, while Salbutamol selectively stimulates β2‑adrenergic receptors, increasing cyclic AMP and causing relaxation of airway smooth muscle. The combined actions produce additive bronchodilation and improve airflow in obstructed airways.

Side Effects

The following adverse reactions have been reported with the inhaled combination of ipratropium bromide and salbutamol.

Common Side Effects

  • Dry mouth: mild to moderate dryness of the oral cavity.
  • Cough: transient irritation leading to coughing.
  • Throat irritation: discomfort or soreness in the throat.
  • Tremor: fine shaking, often of the hands.
  • Headache: mild to moderate headache.
  • Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects

  • Paradoxical bronchospasm: worsening of airway constriction after inhalation.
  • Angioedema: swelling of the face, lips, tongue or throat.
  • Tachyarrhythmia: rapid or irregular heart rhythm.
  • Severe allergic reaction: anaphylaxis with rash, itching, swelling.
  • Chest pain: unexplained discomfort in the chest area.

Precautions & Warnings

Before prescribing Ipratropiumbromide/Salbutamol Sandoz, consider the following safety measures.

  • Assess respiratory status: evaluate baseline lung function and severity of disease.
  • Monitor for paradoxical bronchospasm: watch for worsening breathing after use.
  • Use with caution in cardiovascular disease: beta‑agonists may affect heart rate and blood pressure.
  • Avoid in known hypersensitivity: discontinue if allergic reactions occur.
  • Adjust in renal impairment: consider reduced clearance of ipratropium.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Ipratropiumbromide/Salbutamol Sandoz may interact with other medicines; review patient medication lists.

Major Interactions (Avoid)

  • Beta‑blockers: may diminish bronchodilator effect and precipitate bronchospasm.
  • MAO inhibitors: can increase risk of cardiovascular side effects.
  • Tricyclic antidepressants: may enhance tachycardia and arrhythmias.

Moderate Interactions (Monitor Closely):\n- Theophylline: additive stimulant effect on the heart and CNS.

  • Antihistamines: may increase anticholinergic burden leading to dry mouth or urinary retention.

Frequently Asked Questions

Ipratropiumbromide/Salbutamol Sandoz is prescribed for chronic obstructive pulmonary disease (COPD), asthma and acute bronchospasm. It works by relaxing airway muscles to improve breathing in these respiratory conditions.

Ipratropium bromide blocks muscarinic receptors, preventing acetylcholine‑induced bronchoconstriction, while salbutamol activates β2‑adrenergic receptors, increasing cyclic AMP and causing smooth‑muscle relaxation. Together they provide additive bronchodilation.

The prescribed dose is determined by the treating physician based on the patient’s condition, severity and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly.

Safety data in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The combination offers complementary mechanisms—anticholinergic and β2‑agonist—resulting in greater bronchodilation than either agent alone. This can improve symptom control in patients who need more robust airway relaxation.

Store the inhalation solution at room temperature, below 25 °C, in the original packaging. Keep it away from moisture, heat and direct sunlight to maintain product stability.

The medication is delivered via a metered‑dose inhaler or nebulizer as directed by a healthcare professional. Patients should inhale the dose fully and follow the device’s instructions for proper technique.

Serious adverse events include paradoxical bronchospasm, angioedema, severe allergic reactions, tachyarrhythmias and chest pain. Any of these symptoms require immediate medical attention.

Patients with a known hypersensitivity to ipratropium, salbutamol or any excipients in the formulation should avoid this product. Caution is also advised for individuals with certain cardiovascular disorders or severe renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ipratropium Bromide, Salbutamol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT